MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 12 - per page Next page
Order by
Xclair is a cream, indicated for the management of radiation-induced dermatitis, including relief and management of the most common signs and symptoms such as pruritus, erythema, burning and pain. More
A cancer therapy and diagnostic that utilizes a variation of "Boron Neutron Capture Therapy" to deliver intense, short-lived, therapeutic doses of radiation specifically to active tumor sites. More
This algorithm is used with existing technology to rapidly optimize cancer radiation therapy treatment plans. Also, it has the potential to revolutionize radiation therapy by serving as the platform for adaptive radiation therapy. More
Compositions and methods of use for delivering therapeutic agents transported on or inside nanostructures to target sites for cancer therapy More
Methods of treating cancer and other tumors by coadministration of a radiosensitizing amount of Triapine and ionizing radiation More
Our invention relates to a novel anti-cancer therapy involving the silencing of tumour-derived immunosuppressive genes using siRNA. More
Method for Reducing Radiation Toxicity More
Identification of minimally invasive urine biomarkers for gamma radiation exposure in mammals More
This invention concerns identification of the first serum tumour marker for monitoring the initiation and progression of prostate cancer (CaP) in animal models. More
Name of the inventor: Judah Z. Weinberger An apparatus for reducing restenosis after arterial intervention in the patient's artery. The apparatus is guided by a guide wire within a patient's artery for reducing restenosis after arterial intervention in... More
Displaying 1..10 of 12 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us